|
SKI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54865999999476E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53065999999313E-05 |
| Normal-vs-Stage2 |
3.68060000000003E-06 |
| Normal-vs-Stage3 |
4.618800E-04 |
| Normal-vs-Stage4 |
4.587500E-04 |
| Stage1-vs-Stage2 |
1.948240E-01 |
| Stage1-vs-Stage3 |
6.855800E-01 |
| Stage1-vs-Stage4 |
4.543800E-01 |
| Stage2-vs-Stage3 |
5.903800E-01 |
| Stage2-vs-Stage4 |
9.103000E-01 |
| Stage3-vs-Stage4 |
6.536600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.3615999999469E-06 |
| Normal-vs-AfricanAmerican |
3.249500E-04 |
| Normal-vs-Asian |
1.820810E-04 |
| Caucasian-vs-AfricanAmerican |
9.384000E-01 |
| Caucasian-vs-Asian |
1.525720E-02 |
| AfricanAmerican-vs-Asian |
1.535870E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.45329999999777E-05 |
| Normal-vs-Female |
8.381400E-04 |
| Male-vs-Female |
4.199400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.429300E-04 |
| Normal-vs-Extreme_Weight |
3.96510000000294E-05 |
| Normal-vs-Obese |
1.657240E-03 |
| Normal-vs-Extreme_Obese |
5.188000E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.836600E-01 |
| Normal_Weight-vs-Obese |
3.947000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.563000E-01 |
| Extreme_Weight-vs-Obese |
4.125000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.769600E-01 |
| Obese-vs-Extreme_Obese |
2.752800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.045900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.682000E-03 |
| Normal-vs-Age(61-80Yrs) |
6.6099999995739E-07 |
| Normal-vs-Age(81-100Yrs) |
6.980500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.537400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.060200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.661590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.206000E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.525600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.831600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.961990E-03 |
| Normal-VS-Type2 PRCC |
4.91850005168715E-10 |
| Normal-VS-KIRP CIMP |
2.083800E-01 |
| Normal-VS-Unclassified PRCC |
1.303820E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.99579999998956E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.199800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.658800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.857000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.788300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
6.240400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46409995238628E-09 |
| Normal-vs-N1 |
3.354200E-04 |
| Normal-vs-N2 |
2.022400E-01 |
| N0-vs-N1 |
2.304200E-01 |
| N0-vs-N2 |
1.171760E-01 |
| N1-vs-N2 |
4.791400E-01 |
|
|
